Utilize este identificador para referenciar este registo: https://hdl.handle.net/1822/63284

Registo completo
Campo DCValorIdioma
dc.contributor.authorPuget, Stephaniepor
dc.contributor.authorPhilippe, Cathypor
dc.contributor.authorBax, Dorine Apor
dc.contributor.authorJob, Bastienpor
dc.contributor.authorVarlet, Pascalepor
dc.contributor.authorJunier, Marie-Pierrepor
dc.contributor.authorAndreiuolo, Felipepor
dc.contributor.authorCarvalho, Dinapor
dc.contributor.authorReis, Ricardopor
dc.contributor.authorGuerrini-Rousseau, Leapor
dc.contributor.authorRoujeau, Thomaspor
dc.contributor.authorDessen, Philippepor
dc.contributor.authorRichon, Catherinepor
dc.contributor.authorLazar, Vladimirpor
dc.contributor.authorLe Teuff, Gwenaelpor
dc.contributor.authorSainte-Rose, Christianpor
dc.contributor.authorGeoerger, Birgitpor
dc.contributor.authorVassal, Gillespor
dc.contributor.authorJones, Chrispor
dc.contributor.authorGrill, Jacquespor
dc.date.accessioned2020-01-20T09:08:36Z-
dc.date.available2020-01-20T09:08:36Z-
dc.date.issued2012-
dc.identifier.citationPuget S, Philippe C, Bax DA, Job B, Varlet P, Junier M-P, et al. (2012) Mesenchymal Transition and PDGFRA Amplification/Mutation Are Key Distinct Oncogenic Events in Pediatric Diffuse Intrinsic Pontine Gliomas. PLoS ONE 7(2): e30313. https://doi.org/10.1371/journal.pone.0030313por
dc.identifier.issn1932-6203-
dc.identifier.urihttps://hdl.handle.net/1822/63284-
dc.description.abstractDiffuse intrinsic pontine glioma (DIPG) is one of the most frequent malignant pediatric brain tumor and its prognosis is universaly fatal. No significant improvement has been made in last thirty years over the standard treatment with radiotherapy. To address the paucity of understanding of DIPGs, we have carried out integrated molecular profiling of a large series of samples obtained with stereotactic biopsy at diagnosis. While chromosomal imbalances did not distinguish DIPG and supratentorial tumors on CGHarrays, gene expression profiling revealed clear differences between them, with brainstem gliomas resembling midline/thalamic tumours, indicating a closely-related origin. Two distinct subgroups of DIPG were identified. The first subgroup displayed mesenchymal and pro-angiogenic characteristics, with stem cell markers enrichment consistent with the possibility to grow tumor stem cells from these biopsies. The other subgroup displayed oligodendroglial features, and appeared largely driven by PDGFRA, in particular through amplification and/or novel missense mutations in the extracellular domain. Patients in this later group had a significantly worse outcome with an hazard ratio for early deaths, ie before 10 months, 8 fold greater that the ones in the other subgroup (p = 0.041, Cox regression model). The worse outcome of patients with the oligodendroglial type of tumors was confirmed on a series of 55 paraffin-embedded biopsy samples at diagnosis (median OS of 7.73 versus 12.37 months, p = 0.045, log-rank test). Two distinct transcriptional subclasses of DIPG with specific genomic alterations can be defined at diagnosis by oligodendroglial differentiation or mesenchymal transition, respectively. Classifying these tumors by signal transduction pathway activation and by mutation in pathway member genes may be particularily valuable for the development of targeted therapies.por
dc.description.sponsorshipThe sponsors of the study were the Canceropole Ile de France – Institut National de Cancer (INCa), the LEM-Recherche (Les Entreprises du Médicament), the association “L'Etoile de Martin” and the Association pour la Recherche en Neurochirurgie Pédiatrique (ARNP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.por
dc.language.isoengpor
dc.publisherPublic Library of Science (PLOS)por
dc.rightsopenAccesspor
dc.subjectBrain Stem Neoplasmspor
dc.subjectEpithelial-Mesenchymal Transitionpor
dc.subjectGene Expression Profilingpor
dc.subjectHumanspor
dc.subjectImmunohistochemistrypor
dc.subjectIn Vitro Techniquespor
dc.subjectMutationpor
dc.subjectReceptor, Platelet-Derived Growth Factor alphapor
dc.subjectSignal Transductionpor
dc.subjectSnail Family Transcription Factorspor
dc.subjectTranscription Factorspor
dc.titleMesenchymal transition and PDGFRA amplification/mutation are key distinct oncogenic events in pediatric diffuse intrinsic pontine gliomaspor
dc.typearticlepor
dc.peerreviewedyespor
dc.relation.publisherversionhttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0030313por
oaire.citationIssue2por
oaire.citationVolume7por
dc.identifier.doi10.1371/journal.pone.0030313por
dc.identifier.pmid22389665por
dc.subject.wosScience & Technologypor
sdum.journalPLoS ONEpor
oaire.versionVoRpor
Aparece nas coleções:ICVS - Artigos em revistas internacionais / Papers in international journals

Ficheiros deste registo:
Ficheiro Descrição TamanhoFormato 
journal.pone.0030313.PDF1,49 MBAdobe PDFVer/Abrir

Partilhe no FacebookPartilhe no TwitterPartilhe no DeliciousPartilhe no LinkedInPartilhe no DiggAdicionar ao Google BookmarksPartilhe no MySpacePartilhe no Orkut
Exporte no formato BibTex mendeley Exporte no formato Endnote Adicione ao seu ORCID